Arbutus Biopharma Corporation
ABUS
$3.29
-$0.05-1.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.05% | -10.00% | 9.86% | 2.57% | -6.09% |
| Total Receivables | 41.98% | -7.69% | -24.53% | 15.28% | 9.44% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -35.48% | -26.21% | 7.04% | 6.72% | -30.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -4.11% | -10.42% | 9.09% | 2.91% | -6.77% |
|
|
|||||
| Total Current Assets | -4.11% | -10.42% | 9.09% | 2.91% | -6.77% |
| Net Property, Plant & Equipment | -7.30% | -11.25% | -7.75% | -5.73% | -6.81% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -6.22% | -12.25% | 6.49% | 4.08% | -8.98% |
|
|
|||||
| Total Accounts Payable | 0.04% | -12.71% | -29.15% | 16.13% | 42.61% |
| Total Accrued Expenses | 12.52% | -44.84% | 87.74% | -36.10% | -6.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.21% | 3.31% | -9.76% | 18.12% | 3.16% |
| Total Finance Division Other Current Liabilities | -34.03% | 4.01% | -4.44% | -2.07% | -2.60% |
| Total Other Current Liabilities | -34.03% | 4.01% | -4.44% | -2.07% | -2.60% |
| Total Current Liabilities | -17.47% | -16.25% | 11.33% | -9.74% | 0.73% |
|
|
|||||
| Total Current Liabilities | -17.47% | -16.25% | 11.33% | -9.74% | 0.73% |
| Long-Term Debt | -9.14% | -9.28% | -8.40% | -8.01% | -14.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.59% | -14.51% | -3.13% | -12.06% | -10.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 57.02% | 4.30% | 2.71% | 2.37% | 3.08% |
| Total Liabilities | 2.35% | -10.74% | 5.43% | -7.11% | -2.34% |
|
|
|||||
| Common Stock & APIC | 0.21% | 0.26% | 1.89% | 1.85% | 0.39% |
| Retained Earnings | -0.94% | -1.50% | -1.53% | -1.40% | -1.54% |
| Treasury Stock & Other | -0.09% | 0.45% | 0.13% | 0.10% | 0.95% |
| Total Common Equity | -8.91% | -12.71% | 6.82% | 8.13% | -11.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.91% | -12.71% | 6.82% | 8.13% | -11.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.91% | -12.71% | 6.82% | 8.13% | -11.16% |
|
|
|||||